Arlette M. Vassallo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Arlette M. Vassallo has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- A. John Simpson
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
1 shared publication - Alexander J. T. Wood
Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Australia
1 shared publication - Andrew Conway Morris
Perioperative, Acute, Critical Care and Emergency Medicine Section, Department of Medicine, Addenbrooke’s Hospital, University of Cambridge, Cambridge, UK
1 shared publication - Carmelo Zinnato
Department of Medicine, University of Cambridge, Addenbrooke’s Hospital, Hills Road, Cambridge, United Kingdom
1 shared publication - Carmen Gonzalez-Tejedo
Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom
1 shared publication - Charlotte Summers
Victor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK
1 shared publication
Latest Publications
- Open Access
- 6 August 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (15)
C5a impairs phagosomal maturation in the neutrophil through phosphoproteomic remodeling
Critical illness is accompanied by the release of large amounts of the anaphylotoxin, C5a. C5a suppresses antimicrobial functions of neutrophils which is associated with adverse outcomes. The signaling pathways that mediate C5a-induced neutrophil dysfunction are incompletely understood. Healthy donor neutrophils exposed to purified C5a demonstrated a prolonged defect (7 hours) in phagocytosis of Staphylococcus aureus . Phosphoproteomic profiling of 2712 phosphoproteins identified persistent C5a signaling and selective impairment of phagosomal protein phosphorylation on exposure to S . aureus . Notable proteins included early endosomal marker ZFYVE16 and V-ATPase proton channel component ATPV1G1. An assay of phagosomal acidification demonstrated C5a-induced impairment of phagosomal acidification, which was recapitulated in neutrophils from critically ill patients. Examination of the C5a-impaired protein phosphorylation indicated a role for the PI3K VPS34 in phagosomal maturation. Inhibition of VPS34 impaired neutrophil phagosomal acidification and killing of S . aureus . This study provides a phosphoproteomic assessment of human neutrophil signaling in response to S . aureus and its disruption by C5a, identifying a defect in phagosomal maturation and mechanisms of immune failure in critical illness.
- 6 August 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (15)
Open AccessC5a impairs phagosomal maturation in the neutrophil through phosphoproteomic remodeling
Critical illness is accompanied by the release of large amounts of the anaphylotoxin, C5a. C5a suppresses antimicrobial functions of neutrophils which is associated with adverse outcomes. The signaling pathways that mediate C5a-induced neutrophil dysfunction are incompletely understood. Healthy donor neutrophils exposed to purified C5a demonstrated a prolonged defect (7 hours) in phagocytosis of Staphylococcus aureus . Phosphoproteomic profiling of 2712 phosphoproteins identified persistent C5a signaling and selective impairment of phagosomal protein phosphorylation on exposure to S . aureus . Notable proteins included early endosomal marker ZFYVE16 and V-ATPase proton channel component ATPV1G1. An assay of phagosomal acidification demonstrated C5a-induced impairment of phagosomal acidification, which was recapitulated in neutrophils from critically ill patients. Examination of the C5a-impaired protein phosphorylation indicated a role for the PI3K VPS34 in phagosomal maturation. Inhibition of VPS34 impaired neutrophil phagosomal acidification and killing of S . aureus . This study provides a phosphoproteomic assessment of human neutrophil signaling in response to S . aureus and its disruption by C5a, identifying a defect in phagosomal maturation and mechanisms of immune failure in critical illness.